Donald Trump’s trade record is a lightning rod for debate, marked by aggressive tariffs, strained alliances and a retreat from multilateral agreements under the banner of “America First.” Yet, in his second term, one initiative related to trade stands out as an opportunity: the most favored nation (MFN) drug pricing executive order. The order borrows […]